These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9634925)
61. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome. Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998 [TBL] [Abstract][Full Text] [Related]
62. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice. Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117 [TBL] [Abstract][Full Text] [Related]
64. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700 [TBL] [Abstract][Full Text] [Related]
65. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome. Lieberman SM; Kreiger PA; Koretzky GA Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706 [TBL] [Abstract][Full Text] [Related]
66. LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR. Fava RA; Browning JL; Gatumu M; Skarstein K; Bolstad AI Adv Exp Med Biol; 2011; 691():383-90. PubMed ID: 21153342 [No Abstract] [Full Text] [Related]
67. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome. Barr JY; Wang X; Meyerholz DK; Lieberman SM Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508 [TBL] [Abstract][Full Text] [Related]
68. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome? Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486 [TBL] [Abstract][Full Text] [Related]
69. Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Oak JS; Deane JA; Kharas MG; Luo J; Lane TE; Cantley LC; Fruman DA Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16882-7. PubMed ID: 17071741 [TBL] [Abstract][Full Text] [Related]
70. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome. Pijpe J; Kalk WW; Vissink A J Rheumatol; 2003 Jan; 30(1):206-7; author reply 207. PubMed ID: 12508418 [No Abstract] [Full Text] [Related]
71. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome. Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432 [TBL] [Abstract][Full Text] [Related]
72. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome. Aluri HS; Kublin CL; Thotakura S; Armaos H; Samizadeh M; Hawley D; Thomas WM; Leavis P; Makarenkova HP; Zoukhri D Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5218-28. PubMed ID: 26244298 [TBL] [Abstract][Full Text] [Related]
73. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782 [TBL] [Abstract][Full Text] [Related]
74. Subclass expression of IgA in lacrimal glands of patients with Sjögren's syndrome. Ono M; Yoshino K; Tsubota K; Saito I Adv Exp Med Biol; 1994; 350():185-8. PubMed ID: 8030473 [No Abstract] [Full Text] [Related]
75. An investigation of interactions between the immune system and stimulus-secretion coupling in mouse submandibular acinar cells. A possible mechanism to account for reduced salivary flow rates associated with the onset of Sjögren's syndrome. Dawson LJ; Christmas SE; Smith PM Rheumatology (Oxford); 2000 Nov; 39(11):1226-33. PubMed ID: 11085802 [TBL] [Abstract][Full Text] [Related]
77. Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjögren's syndrome. Sullivan DA; Sato EH Clin Immunol Immunopathol; 1992 Jul; 64(1):9-16. PubMed ID: 1606757 [No Abstract] [Full Text] [Related]
78. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability. Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769 [TBL] [Abstract][Full Text] [Related]
79. Potentially pathogenic immune cells and networks in apparently healthy lacrimal glands. Mircheff AK; Wang Y; Ding C; Warren DW; Schechter JE Ocul Surf; 2015 Jan; 13(1):47-81. PubMed ID: 25557346 [TBL] [Abstract][Full Text] [Related]
80. Sjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus. Nguyen C; Singson E; Kim JY; Cornelius JG; Attia R; Doyle ME; Bulosan M; Cha S; Peck AB Scand J Immunol; 2006 Sep; 64(3):295-307. PubMed ID: 16918699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]